{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:12:32Z","timestamp":1775329952565,"version":"3.50.1"},"reference-count":134,"publisher":"Elsevier","isbn-type":[{"value":"9780123749697","type":"print"}],"license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1016\/s0076-6879(09)64006-4","type":"book-chapter","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:19:09Z","timestamp":1258003149000},"page":"105-129","source":"Crossref","is-referenced-by-count":84,"title":["Solid Lipid Nanoparticle Formulations: Pharmacokinetic and Biopharmaceutical Aspects in Drug Delivery"],"prefix":"10.1016","author":[{"given":"Eliana B.","family":"Souto","sequence":"first","affiliation":[]},{"given":"Slavomira","family":"Doktorovov\u00e1","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0076-6879(09)64006-4_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","article-title":"Diazepam-loaded solid lipid nanoparticles: Design and characterization","volume":"10","author":"Abdelbary","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/S0076-6879(09)64006-4_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s11095-007-9234-3","article-title":"Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro type pHIS-HIV-Hugag transfection","volume":"24","author":"Asasutjarit","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.12.007","article-title":"Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct","volume":"355","author":"Attama","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/02652040701532981","article-title":"Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability","volume":"24","author":"Battaglia","year":"2007","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-511X-8-6","article-title":"Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies","volume":"8","author":"Bhaskar","year":"2009","journal-title":"Lipids Health Dis."},{"key":"10.1016\/S0076-6879(09)64006-4_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/03639040802192822","article-title":"Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: In vitro and in vivo characteristics","volume":"35","author":"Bhaskar","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1166\/jbn.2009.036","article-title":"Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery","volume":"5","author":"Bi","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157341309787314575","article-title":"Solid lipid nanoparticles containing nimesulide: Preparation, characterization and cytotoxicity studies","volume":"5","author":"Bondi","year":"2009","journal-title":"Curr. Nanosci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/157341309787314656","article-title":"Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimers disease: Preparation, characterization and cytotoxicity studies","volume":"5","author":"Bondi","year":"2009","journal-title":"Curr. Nanosci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1179\/016164107X187017","article-title":"Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors?","volume":"29","author":"Brioschi","year":"2007","journal-title":"Neurol. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/molecules13020230","article-title":"Cholesteryl butyrate solid lipid nanoparticles as a butyric acid prodrug","volume":"13","author":"Brioschi","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/S0076-6879(09)64006-4_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.addr.2007.04.013","article-title":"Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering","volume":"59","author":"Bunjes","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/S0076-6879(09)64006-4_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2006.06.012","article-title":"Solid lipid nanoparticles incorporated in dextran hydrogels: A new drug delivery system for oral formulations","volume":"325","author":"Casadei","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/02652040701288519","article-title":"Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne","volume":"24","author":"Castro","year":"2007","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1467-2494.2006.00320.x","article-title":"Sunblocking efficiency of various TiO(2)-loaded solid lipid nanoparticle formulations(1)","volume":"28","author":"Cengiz","year":"2006","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib16","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s11095-008-9615-2","article-title":"Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line","volume":"25","author":"Chattopadhyay","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2005.09.052","article-title":"Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting","volume":"110","author":"Chen","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_rf0090","first-page":"172","article-title":"Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins","volume":"64","author":"de Ven","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/sj.bjp.0706761","article-title":"Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells","volume":"148","author":"Dianzani","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2008.11.012","article-title":"Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization","volume":"72","author":"Dong","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib22","first-page":"P259","article-title":"Baclofen-loaded solid lipid nanoparticles administration in rats: Pharmacokinetics and neurophysiological study","author":"El Assawy","year":"2008"},{"key":"10.1016\/S0076-6879(09)64006-4_bib23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11095-007-9514-y","article-title":"Solid lipid nanoparticles as delivery systems for bromocriptine","volume":"25","author":"Esposito","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib24","first-page":"150","article-title":"Development and characterization of carvedilol-loaded solid lipid nanoparticles","volume":"60","author":"Faisal","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats","volume":"42","author":"Fundaro","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib27","first-page":"1","article-title":"Preparation of solid lipid nanoparticles from W\/O\/W emulsions: Preliminary studies on insulin encapsulation","author":"Gallarate","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gokce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/03639040701833708","article-title":"Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen","volume":"34","author":"Han","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2885.2008.01009.x","article-title":"Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: In vitro and in vivo studies","volume":"32","author":"Han","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/S0076-6879(09)64006-4_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","article-title":"Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug","volume":"59","author":"Hanafy","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/S0076-6879(09)64006-4_bib32","doi-asserted-by":"crossref","first-page":"N1","DOI":"10.1111\/j.1750-3841.2007.00641.x","article-title":"Beta-carotene-loaded nanostructured lipid carriers","volume":"73","author":"Hentschel","year":"2008","journal-title":"J. Food Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10544-008-9192-5","article-title":"Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery","volume":"10","author":"Hsu","year":"2008","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/S0076-6879(09)64006-4_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2006.01.040","article-title":"Preparation and characteristics of monostearin nanostructured lipid carriers","volume":"314","author":"Hu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijpharm.2007.12.013","article-title":"Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity","volume":"355","author":"Huang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_rf0180","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and evaluation of lipid nanoparticles for camptothecin delivery: A comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/S0076-6879(09)64006-4_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02652040500444198","article-title":"DEET-loaded solid lipid particles for skin delivery: In vitro release and skin permeation characteristics in different vehicles","volume":"23","author":"Iscan","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jbm.b.30994","article-title":"Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery","volume":"86B","author":"Jain","year":"2008","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"10.1016\/S0076-6879(09)64006-4_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02652040701799598","article-title":"Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting","volume":"25","author":"Jain","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejpb.2005.12.007","article-title":"Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles","volume":"63","author":"Jee","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib41","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1021\/la050175s","article-title":"Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate\/glycerol dioleate mixtures","volume":"21","author":"Johnsson","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/S0076-6879(09)64006-4_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/03639040600814676","article-title":"Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib","volume":"32","author":"Joshi","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2007.05.060","article-title":"Nanostructured lipid carrier (NLC) based gel of celecoxib","volume":"346","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","article-title":"Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject","volume":"364","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2008.08.019","article-title":"Nanoparticles for skin penetration enhancement\u2014A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles","volume":"71","author":"Kuchler","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2006.11.004","article-title":"Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics","volume":"335","author":"Kumar","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.colsurfb.2005.05.007","article-title":"Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers","volume":"44","author":"Kuntsche","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/S0076-6879(09)64006-4_bib48","first-page":"206","article-title":"Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles","volume":"365","author":"Kuo","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.03.012","article-title":"Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles","volume":"340","author":"Kuo","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib50","first-page":"1180","article-title":"Preparation and characterization of bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) loaded solid lipid nano-particles (SLN)","volume":"13","author":"Lee","year":"2007","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/S0076-6879(09)64006-4_bib51","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.biomaterials.2007.01.014","article-title":"Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles","volume":"28","author":"Lee","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/S0076-6879(09)64006-4_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","article-title":"Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles","volume":"133","author":"Li","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_rf0270","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/10611860801902351","article-title":"Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate","volume":"16","author":"Lian","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/S0076-6879(09)64006-4_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","article-title":"Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery","volume":"328","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","article-title":"Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery","volume":"328","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/03639040701662230","article-title":"Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers","volume":"34","author":"Liu","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2008.08.013","article-title":"Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate","volume":"364","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2005.09.045","article-title":"Lipid nanoparticles for skin penetration enhancement\u2013correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy","volume":"110","author":"Lombardi Borgia","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2006.01.001","article-title":"Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases","volume":"28","author":"Lu","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2006.01.001","article-title":"Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases","volume":"28","author":"Lu","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12248-008-9013-z","article-title":"Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: Optimization and in vitro characterization","volume":"10","author":"Lu","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/S0076-6879(09)64006-4_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2006.05.010","article-title":"Solid lipid nanoparticles for enhancing vinpocetine\u2019s oral bioavailability","volume":"114","author":"Luo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2009.01.014","article-title":"Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery","volume":"372","author":"Lv","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","article-title":"Development of SLNs from natural lipids: Application to topical delivery of tretinoin","volume":"363","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2005.06.006","article-title":"Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"107","author":"Manjunath","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib69","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10611860600888850","article-title":"Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"14","author":"Manjunath","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/S0076-6879(09)64006-4_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.carbpol.2007.02.012","article-title":"Insulin-loaded alginate microspheres for oral delivery\u2014Effect of polysaccharide reinforcement on physicochemical properties and release profile","volume":"69","author":"Martins","year":"2007","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/S0076-6879(09)64006-4_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1166\/jbn.2009.443","article-title":"Improving oral absorption of samon calcitonin by trimyristin lipid nanoparticles","volume":"5","author":"Martins","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_rf0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(96)04731-X","article-title":"Biodegradation of solid lipid nanoparticles as a function of lipase incubation time","volume":"144","author":"M\u00fcller","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib73","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/S0076-6879(09)64006-4_bib74","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.02.045","article-title":"Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN\u00ae) versus drug nanocrystals","volume":"317","author":"M\u00fcller","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","article-title":"Nanostructured lipid carriers (NLC) in cosmetic dermal products","volume":"59","author":"M\u00fcller","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/S0076-6879(09)64006-4_bib76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpb.2007.07.006","article-title":"Cyclosporine-loaded solid lipid nanoparticles (SLN): Drug-lipid physicochemical interactions and characterization of drug incorporation","volume":"68","author":"M\u00fcller","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(02)00035-2","article-title":"Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)\u2014Effect of surfactants, storage time and crystallinity","volume":"237","author":"Olbrich","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/S0076-6879(09)64006-4_bib79","first-page":"1","article-title":"Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs","author":"Paolicelli","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib81","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1021\/cm061993o","article-title":"Solid lipid nanoparticles of p-hexanoyl calix[4]arene as a controlling agent in the photochemistry of a sunscreen blocker","volume":"18","author":"Pojarova","year":"2006","journal-title":"Chem. Mater."},{"key":"10.1016\/S0076-6879(09)64006-4_bib82","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1039\/b803296c","article-title":"Inclusion of 4-methoxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl in a calixarene nanocapsule in the solid state","volume":"10","author":"Polovyanenko","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/S0076-6879(09)64006-4_bib83","doi-asserted-by":"crossref","DOI":"10.1208\/pt070491","article-title":"Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A","volume":"7","author":"Pople","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/S0076-6879(09)64006-4_bib84","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1166\/jnn.2007.809","article-title":"Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems","volume":"7","author":"Priano","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpharm.2008.01.045","article-title":"Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation","volume":"357","author":"Puglia","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib86","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1007\/BF02854895","article-title":"Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton\u2019s lymphoma bearing mice","volume":"8","author":"Reddy","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/S0076-6879(09)64006-4_bib87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-079X.2008.00651.x","article-title":"Melatonin delivery in solid lipid nanoparticles: Prevention of cyclosporine A induced cardiac damage","volume":"46","author":"Rezzani","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/S0076-6879(09)64006-4_rf0440","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1166\/jnn.2006.457","article-title":"Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma","volume":"6","author":"Ruckmani","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib89","first-page":"2991","article-title":"Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma","author":"Ruckmani","year":"2006"},{"key":"10.1016\/S0076-6879(09)64006-4_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1208\/s12249-009-9193-6","article-title":"Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid","volume":"10","author":"Ruktanonchai","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/S0076-6879(09)64006-4_bib91","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10611860902718672","article-title":"Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement","volume":"17","author":"Sanjula","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/S0076-6879(09)64006-4_bib92","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/S0076-6879(09)64006-4_bib93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/03639040802244300","article-title":"Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles","volume":"35","author":"Scalia","year":"2009","journal-title":"Drug Dev.Ind. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib94","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1166\/jnn.2006.423","article-title":"Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines","volume":"6","author":"Serpe","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","article-title":"Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery","volume":"345","author":"Shah","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib96","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1021\/la801083h","article-title":"Amino-substituted amphiphilic calixarenes: Self-assembly and interactions with DNA","volume":"24","author":"Shahgaldian","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/S0076-6879(09)64006-4_bib97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2008.09.032","article-title":"Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil","volume":"367","author":"Sharma","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib98","first-page":"177","article-title":"Minoxidil-loaded nanostructured lipid carriers (NLC): Characterization and rheological behaviour of topical formulations","volume":"64","author":"Silva","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib99","first-page":"431","article-title":"The use of SLN (R) and NLC (R) as topical particulate carriers for imidazole antifungal agents","volume":"61","author":"Souto","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib100","series-title":"Nanoparticles for Pharmaceutical Applications","first-page":"103","article-title":"Lipid nanoparticles (SLN and NLC) for drug delivery","author":"Souto","year":"2007"},{"key":"10.1016\/S0076-6879(09)64006-4_bib101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","article-title":"Cosmetic features and applications of lipid nanoparticles (SLN, NLC)","volume":"30","author":"Souto","year":"2008","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib102","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/02652040600612439","article-title":"Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib103","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1166\/jbn.2007.049","article-title":"Lipid nanoparticles (SLN\u00ae, NLC\u00ae) for cutaneous drug delivery: Structure, protection and skin effects","volume":"3","author":"Souto","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib104","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11095-006-9225-9","article-title":"Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterisation and skin uptake","volume":"24","author":"Stecova","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1208\/pt0801024","article-title":"Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles","volume":"8","author":"Suresh","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/S0076-6879(09)64006-4_rf0530","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1245\/s10434-008-0041-9","article-title":"Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: Findings from the Austrian Sentinel Node Study Group","volume":"15","author":"Tausch","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2007.03.022","article-title":"Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)\u2014Effects of formulation parameters on physicochemical stability","volume":"340","author":"Teeranachaideekul","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2007.01.015","article-title":"Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10)\u2014Development, physicochemical characterization and in vitro release studies","volume":"67","author":"Teeranachaideekul","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2008.02.011","article-title":"Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC","volume":"128","author":"Teeranachaideekul","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02652040701817762","article-title":"Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels)","volume":"25","author":"Teeranachaideekul","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib111","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2008.02.011","article-title":"Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC","volume":"128","author":"Teeranachaideekul","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_bib112","first-page":"593","article-title":"Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin","volume":"63","author":"Tian","year":"2008","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib113","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11051-008-9402-3","article-title":"Optimization of beta-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique","volume":"11","author":"Triplett","year":"2009","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib114","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1061186021000054933","article-title":"Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles","volume":"10","author":"Videira","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/S0076-6879(09)64006-4_bib115","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1208\/pt0804083","article-title":"Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles","volume":"8","author":"Vivek","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/S0076-6879(09)64006-4_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10717540500315930","article-title":"In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages","volume":"13","author":"Wang","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/S0076-6879(09)64006-4_bib117","first-page":"110","article-title":"Preparation and characterization of solid lipid nanoparticles loaded with total flavones of Hippophae rhamnoides (TFH)","volume":"61","author":"Wang","year":"2007","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/S0076-6879(09)64006-4_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02652040902746679","article-title":"Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: Lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles","author":"Wang","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0378-5173(02)00220-X","article-title":"The influence of the crystallinity of lipid nanoparticles on their occlusive properties","volume":"242","author":"Wissing","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-2494.2007.00410.x","article-title":"Nanostructured lipid carriers as novel carrier for sunscreen formulations","volume":"29","author":"Xia","year":"2007","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02980228","article-title":"Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles","volume":"30","author":"Xiang","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/S0076-6879(09)64006-4_bib122","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/S0076-6879(09)64006-4_bib123","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/S0076-6879(09)64006-4_rf0620","first-page":"86","article-title":"Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles","volume":"64","author":"Yang","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2007.10.014","article-title":"Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis","volume":"352","author":"Ye","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib126","first-page":"878","article-title":"Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release","volume":"63","author":"Ying","year":"2008","journal-title":"Pharmazie"},{"key":"10.1016\/S0076-6879(09)64006-4_bib127","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2007.03.002","article-title":"Studies on oral absorption of stearic acid SLN by a novel fluorometric method","volume":"58","author":"Yuan","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/S0076-6879(09)64006-4_bib128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2007.07.012","article-title":"Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells","volume":"348","author":"Yuan","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0076-6879(09)64006-4_bib129","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jps.10129","article-title":"Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats","volume":"91","author":"Zara","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S0076-6879(09)64006-4_bib130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/S0076-6879(09)64006-4_bib131","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10717540701203034","article-title":"Preparation and characterization of solid lipid nanoparticles containing silibinin","volume":"14","author":"Zhang","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/S0076-6879(09)64006-4_bib132","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02652040701852181","article-title":"Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake","volume":"25","author":"Zhang","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/S0076-6879(09)64006-4_bib133","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1248\/cpb.56.1645","article-title":"Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying","volume":"56","author":"Zhang","year":"2008","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/S0076-6879(09)64006-4_bib134","doi-asserted-by":"crossref","first-page":"55702","DOI":"10.1088\/0957-4484\/20\/5\/055702","article-title":"Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles","volume":"20","author":"Zhu","year":"2009","journal-title":"Nanotechnology"}],"container-title":["Methods in Enzymology","Liposomes, Part F"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687909640064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687909640064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:48:01Z","timestamp":1558640881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687909640064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9780123749697"],"references-count":134,"URL":"https:\/\/doi.org\/10.1016\/s0076-6879(09)64006-4","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}